Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.

Sorà F, Chiusolo P, Laurenti L, Autore F, Giammarco S, Sica S.

Mediterr J Hematol Infect Dis. 2016 Jul 1;8(1):e2016027. doi: 10.4084/MJHID.2016.027. eCollection 2016.

2.

A Pediatric Acute Promyelocytic Leukemia With a Rare Karyotype of ider(17)(q10)t(15;17) and Favorable Outcome: A Case Report.

He Y, Wang P, Liang K, Chen X, Du W, Li J, Hu Y, Bai Y, Liu W, Li X, Jin R, Zhang M, Zheng J.

Medicine (Baltimore). 2015 Oct;94(41):e1778. doi: 10.1097/MD.0000000000001778.

3.

Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.

Abrahão R, Ribeiro RC, Medeiros BC, Keogh RH, Keegan TH.

Cancer. 2015 Nov 15;121(22):3990-7. doi: 10.1002/cncr.29631. Epub 2015 Aug 11.

PMID:
26264598
4.

Acute promyelocytic leukemia: where did we start, where are we now, and the future.

Coombs CC, Tavakkoli M, Tallman MS.

Blood Cancer J. 2015 Apr 17;5:e304. doi: 10.1038/bcj.2015.25. Review.

5.

Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis.

Percival ME, Tao L, Medeiros BC, Clarke CA.

Cancer. 2015 Jun 15;121(12):2004-12. doi: 10.1002/cncr.29319. Epub 2015 Mar 4.

6.

A review of arsenic trioxide and acute promyelocytic leukemia.

Alimoghaddam K.

Int J Hematol Oncol Stem Cell Res. 2014 Jul 1;8(3):44-54. Review.

7.

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults.

Seftel MD, Barnett MJ, Couban S, Leber B, Storring J, Assaily W, Fuerth B, Christofides A, Schuh AC.

Curr Oncol. 2014 Oct;21(5):234-50. doi: 10.3747/co.21.2183.

8.

New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.

Zeidan AM, Gore SD.

Clin Cancer Res. 2014 Oct 1;20(19):4985-93. doi: 10.1158/1078-0432.CCR-13-2725. Review.

10.

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults.

Testi AM, D'Angiò M, Locatelli F, Pession A, Lo Coco F.

Mediterr J Hematol Infect Dis. 2014 Apr 15;6(1):e2014032. doi: 10.4084/MJHID.2014.032. eCollection 2014. Review.

11.

Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis.

Brunner AM, Blonquist TM, Sadrzadeh H, Perry AM, Attar EC, Amrein PC, Ballen KK, Chen YB, Neuberg DS, Fathi AT.

Leuk Res. 2014 Jul;38(7):773-80. doi: 10.1016/j.leukres.2014.04.001. Epub 2014 Apr 12.

12.

Clinical characteristics of acute promyelocytic leukemia manifesting as early death.

He B, Hu S, Qiu G, Gu W.

Mol Clin Oncol. 2013 Sep;1(5):908-910. Epub 2013 Jul 23.

13.

Contemporary treatment of APL.

Cull EH, Altman JK.

Curr Hematol Malig Rep. 2014 Jun;9(2):193-201. doi: 10.1007/s11899-014-0205-6. Review.

14.

Acute myeloid leukemia, version 2.2013.

O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1047-55.

15.

Management of acute promyelocytic leukemia in the elderly.

Lo-Coco F, Latagliata R, Breccia M.

Mediterr J Hematol Infect Dis. 2013 Jun 8;5(1):e2013045. doi: 10.4084/MJHID.2013.045. Print 2013.

16.

Management of elderly patients with acute promyelocytic leukemia: progress and problems.

Lengfelder E, Hofmann WK, Nolte F.

Ann Hematol. 2013 Sep;92(9):1181-8. doi: 10.1007/s00277-013-1788-z. Epub 2013 May 22. Review.

17.

Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.

Costa LJ, Xavier AC, Wahlquist AE, Hill EG.

Blood. 2013 Jun 13;121(24):4861-6. doi: 10.1182/blood-2012-12-475558. Epub 2013 May 2.

19.

All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.

Douer D, Zickl LN, Schiffer CA, Appelbaum FR, Feusner JH, Shepherd L, Willman CL, Bloomfield CD, Paietta E, Gallagher RE, Park JH, Rowe JM, Wiernik PH, Tallman MS.

Leuk Res. 2013 Jul;37(7):795-801. doi: 10.1016/j.leukres.2013.03.001. Epub 2013 Mar 23.

20.

Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.

Lengfelder E, Hanfstein B, Haferlach C, Braess J, Krug U, Spiekermann K, Haferlach T, Kreuzer KA, Serve H, Horst HA, Schnittger S, Aul C, Schultheis B, Erben P, Schneider S, Müller-Tidow C, Wörmann B, Berdel WE, Sauerland C, Heinecke A, Hehlmann R, Hofmann WK, Hiddemann W, Büchner T; German Acute Myeloid Leukemia Cooperative Group (AMLCG).

Ann Hematol. 2013 Jan;92(1):41-52. doi: 10.1007/s00277-012-1597-9. Epub 2012 Oct 23.

Items per page

Supplemental Content

Write to the Help Desk